Delicate balance among three types of T cells in concurrent regulation of tumor immunity. - Wikidata - awgldk - TriplyDB

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

http://www.wikidata.org/entity/Q36755513

about

NKT cell networks in the regulation of tumor immunity The immunoregulatory role of type I and type II NKT cells in cancer and other diseases Dendritic cells and anergic type I NKT cells play a crucial role in sulfatide-mediated immune regulation in experimental autoimmune encephalomyelitis Lipid antigens in immunity.Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance.CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer.Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.Balance is a key for happiness.Driving CAR-based T-cell therapy to success.The tumor microenvironment: a pitch for multiple players.The functional and prognostic implications of regulatory T cells in colorectal carcinoma.Immunotherapeutic strategies targeting natural killer T cell responses in cancer.Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.Synthesis of a 2"-deoxy-β-GalCer Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.Tumor-infiltrating CD4+ T cells in patients with gastric cancer.Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.Stem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis Tissue-Specific Roles of NKT Cells in Tumor Immunity

P2860

Q26866223-D6D6BC05-93D6-4695-80B1-D021DDD55128 Q27027556-F8240780-6EED-4758-B062-0E732099C336 Q33948634-A0A961C4-A32C-4BC0-9909-8BC842993A94 Q34025822-C42B58D0-7A92-45A8-ADC3-2DE1C02AECD4 Q34381246-42D34114-2A2B-47E1-B170-9B3757DA994F Q34621578-B2F7F48B-601E-476D-BB79-021CFA9C1FC9 Q35103549-9A0AED1E-2C01-4B2F-9FF0-261853CB9B9B Q35750702-CE124F50-38E1-4F0D-B24E-A1238670A7CB Q36299762-DB67235B-2302-4279-9AAE-6D92F5A528FC Q36536034-BD336298-6EF3-4BE5-A469-7654A07C08CF Q36887825-119C3784-4A21-4B9A-991A-779897D6E372 Q37715684-6880CA6F-5742-4DC9-826B-99ED6F94E1BB Q38101567-9F77AED8-5A38-4F39-8C65-B4DCE339C7AC Q38510263-F59AF527-B928-47E3-9049-E53166F9FB52 Q38890717-BA6126CB-6824-43C3-9984-A10D533A44AC Q38894017-0F2FC681-5478-485E-B0BC-2DD4DC7E56E1 Q38954685-6508E371-1FA8-4CE6-B990-740A9CCA50AA Q39196835-4F915495-E093-43CC-B38A-45FC9CA8CD9D Q39958212-8841B783-D04B-48A1-BE12-92EA5F10D2AA Q45966276-E793CCB4-1275-4AE2-B195-D28662C856D9 Q47099025-E1879F7A-C86C-44F0-A4B2-780E3CCCC928 Q49331836-4450F632-3372-4790-82AC-F92B63A21ADB Q50075685-885BBC3F-68D8-44A8-9DE2-E2176089D423 Q55267052-341E9B4D-B4A5-416A-8CE3-C792681176FA Q58199154-3465AEE5-7014-4D1E-8881-C8BC15B64467 Q58777562-198863FD-0FB0-4FC3-8E85-F9FEE81FA8E5

P2860

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

http://www.wikidata.org/entity/Q36755513

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@ast

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@en

type

label

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@ast

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@en

prefLabel

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@ast

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@en

P1433

Q36755513-6E769277-39B9-4BCA-8334-E94D383390B4

P1476

Q36755513-4BF7506C-6C46-40FE-8070-36C337332362

P2093

Q36755513-085C6CF4-2CBD-48C0-8D37-4D6C1B9679D4

Q36755513-15735811-8628-44F7-85B9-B361607BBEF2

Q36755513-1904CCE6-6773-4A58-9FF0-774F6B5C02A5

Q36755513-3FFECA08-D859-467E-A8B9-6D351C00909F

Q36755513-8DD3CA08-53D5-47B3-BAA7-A067D1B29870

Q36755513-B6928B24-DADF-48CC-BAF7-CE8E641EA88D

Q36755513-BAD51B89-DDE6-4DF1-B615-C3BE20E95B82

Q36755513-D6BFBB9E-CC05-4F3A-9ADE-F33876AB7499

Q36755513-F4E7F69C-B588-4203-BC2D-4DC15D5EBB85

Q36755513-FD1317A9-1393-4780-9241-031BCB974FDE

P2860

Q36755513-007EFC8E-5027-4C8A-AF70-348388B3229B

Q36755513-048EBC3A-55C6-4E99-916A-F09DECA4E7FA

Q36755513-1070E20F-15C7-455B-8364-7B35ED2F9B29

Q36755513-1A33CB0A-8496-44E8-B88D-24CB95F25905

Q36755513-1B74D4F1-628E-48B1-B09B-004E8320F61F

Q36755513-284BB408-2C0A-4CC0-801D-D2F503702465

Q36755513-2939762A-67BC-4A2A-A987-ED17BF85ADAE

Q36755513-2D39DB37-6E4C-4159-B6DB-2EF8116E2679

Q36755513-3E2E2EFD-91B6-4546-8499-5078BD5BE737

Q36755513-41ACB41A-427A-41DA-ADEA-3C85F9C551AA

P304

Q36755513-EEEA10AF-F027-4E2C-ADDA-B4F9E506838E

P31

Q36755513-855DE5BB-535C-449A-8B89-2C6DB21168E9

P356

Q36755513-7B7FBC05-8BD0-4CDB-BB93-41C1D43394FA

P407

Q36755513-9874487C-3F6B-41CD-AE51-17B64BD6D030

P433

Q36755513-0747A0C7-C60F-4AE7-9B12-E6A43AF0F9C6

P478

Q36755513-6131F1CC-C4B6-4E34-9702-ABD7FB5E6757

P577

Q36755513-B6E73AD9-4ED5-4C37-BAE7-2071B3262F7E

P698

Q36755513-61F32ACC-E1BA-43FB-8AA2-DD7A7E300D95

P932

Q36755513-EEE2E92A-A8BF-48BB-AAE2-C5D6B40C65C3

P356

0008-5472.CAN-12-2567

P1433

Cancer Research

P1476

Delicate balance among three types of T cells in concurrent regulation of tumor immunity.

@en

P2093

David Venzon

http://www.w3.org/2001/XMLSchema#string

Elena Ambrosino

http://www.w3.org/2001/XMLSchema#string

Hannah Weber

http://www.w3.org/2001/XMLSchema#string

Jay A Berzofsky

http://www.w3.org/2001/XMLSchema#string

Jessica J O'Konek

http://www.w3.org/2001/XMLSchema#string

Liat Izhak

http://www.w3.org/2001/XMLSchema#string

Masaki Terabe

http://www.w3.org/2001/XMLSchema#string

Shingo Kato

http://www.w3.org/2001/XMLSchema#string

Stanley T Parish

http://www.w3.org/2001/XMLSchema#string

Zheng Xia

http://www.w3.org/2001/XMLSchema#string

P2860

The role of NKT cells in tumor immunity

A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties

The three Es of cancer immunoediting

Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.

Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials.

Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody.

CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12.

CD1d activation and blockade: a new antitumor strategy

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

Mouse and human iNKT cell agonist β-mannosylceramide reveals a distinct mechanism of tumor immunity.

P304

1514-1523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-2567

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23319803

http://www.w3.org/2001/XMLSchema#string

P932

3622595

http://www.w3.org/2001/XMLSchema#string